LU51306A1 - - Google Patents

Info

Publication number
LU51306A1
LU51306A1 LU51306A LU51306A LU51306A1 LU 51306 A1 LU51306 A1 LU 51306A1 LU 51306 A LU51306 A LU 51306A LU 51306 A LU51306 A LU 51306A LU 51306 A1 LU51306 A1 LU 51306A1
Authority
LU
Luxembourg
Application number
LU51306A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU51306A1 publication Critical patent/LU51306A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU51306A 1965-06-15 1966-06-13 LU51306A1 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB25289/65A GB1136214A (en) 1965-06-15 1965-06-15 Thebaine and oripavine derivatives

Publications (1)

Publication Number Publication Date
LU51306A1 true LU51306A1 (pt) 1966-08-16

Family

ID=10225305

Family Applications (1)

Application Number Title Priority Date Filing Date
LU51306A LU51306A1 (pt) 1965-06-15 1966-06-13

Country Status (14)

Country Link
AT (1) AT272530B (pt)
BE (1) BE682551A (pt)
BR (1) BR6680359D0 (pt)
CH (1) CH558362A (pt)
DE (1) DE1620206A1 (pt)
DK (1) DK115926B (pt)
ES (1) ES327925A1 (pt)
FI (1) FI49724C (pt)
FR (1) FR6395M (pt)
GB (1) GB1136214A (pt)
LU (1) LU51306A1 (pt)
NL (1) NL6608255A (pt)
NO (1) NO119590B (pt)
SE (1) SE325276B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2554816B1 (fr) * 1983-11-16 1986-09-26 Sanofi Sa Nouveau derive de la nororipavine presentant a la fois une activite agoniste et antagoniste des recepteurs morphiniques
KR100204659B1 (ko) * 1996-05-28 1999-06-15 강재헌 신규한 부프레노핀계 진통제용 화합물
AUPQ968300A0 (en) 2000-08-25 2000-09-21 Glaxo Wellcome Australia Ltd Chemical methods
GB2388369B (en) * 2002-05-10 2004-05-05 Reckitt Benckiser Healthcare Demethylation of thebaine derivative
GB0421687D0 (en) 2004-09-30 2004-11-03 Johnson Matthey Plc Preparation of opiate analgesics
US8703099B2 (en) 2005-02-24 2014-04-22 Dr Pharma Nova, Llc Registry method and control system for DEA schedule II-V medicines
DE102006054731B4 (de) 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
KR101343395B1 (ko) 2008-07-30 2013-12-19 퍼듀 퍼머 엘피 부프레노르핀 유사체
WO2010039216A1 (en) * 2008-09-30 2010-04-08 Mallinckrodt Inc. Processes for the alkylation of norbuprenorphine with reduced impurity formation
NZ595591A (en) 2009-04-24 2013-11-29 Univ Brock Processes for the preparation of morphinane and morphinone compounds
GB201111775D0 (en) 2011-07-08 2011-08-24 Univ Bath Compounds and uses thereof
TW201338813A (zh) 2011-12-12 2013-10-01 Lohmann Therapie Syst Lts 經皮遞送系統
SI2877155T1 (sl) 2012-07-26 2021-04-30 Camurus Ab Opioidne formulacije
AR094641A1 (es) * 2012-12-07 2015-08-19 Purdue Pharma Lp Análogos de buprenorfina
BR112015029920A2 (pt) 2013-06-04 2017-07-25 Lts Lohmann Therapie Systeme Ag sistema de administração transdérmica
WO2023111125A1 (en) 2021-12-16 2023-06-22 Arevipharma Gmbh Method of making buprenorphine and precursor compounds thereof

Also Published As

Publication number Publication date
GB1136214A (en) 1968-12-11
FI49724B (pt) 1975-06-02
BR6680359D0 (pt) 1973-12-26
BE682551A (pt) 1966-11-14
NO119590B (pt) 1970-06-08
FR6395M (pt) 1968-10-21
DE1620206A1 (de) 1970-03-19
CH558362A (de) 1975-01-31
DK115926B (da) 1969-11-24
SE325276B (pt) 1970-06-29
FI49724C (fi) 1975-09-10
NL6608255A (pt) 1966-12-16
ES327925A1 (es) 1967-04-01
AT272530B (de) 1969-07-10

Similar Documents

Publication Publication Date Title
FR6395M (pt)
FR6153M (pt)
JPS4314768Y1 (pt)
JPS4322323Y1 (pt)
JPS4217555Y1 (pt)
JPS4314165Y1 (pt)
AU416352B2 (pt)
JPS437081Y1 (pt)
JPS4217132Y1 (pt)
AU6361565A (pt)
AU6521465A (pt)
BE674723A (pt)
NL6511440A (pt)
BE662956A (pt)
NL6506911A (pt)
BE667273A (pt)
BE666856A (pt)
NL6608296A (pt)
NL6612744A (pt)
BE665744A (pt)
BE678291A (pt)
BE674905A (pt)
BE674887A (pt)
BE674854A (pt)
BE674818A (pt)